From the RNA world to the clinic.
From the RNA world to the clinic.
复制标题
DOI:
10.1126/science.aad8709
复制
发表时间:
2016-06-17
期刊:
影响因子:
--
通讯作者:
Nair S
中科院分区:
文献类型:
--
作者:
Sullenger BA;Nair S
The study of RNA has continually emphasized the structural and functional versatility of RNA molecules. This versatility has inspired translational and clinical researchers to explore the utility of RNA-based therapeutic agents for a wide variety of medical applications. Several RNA therapeutics, with diverse modes of action, are being evaluated in large late-stage clinical trials, and many more are in early clinical development. Hundreds of patients are enrolled in large trials testing messenger RNAs to combat cancer, small interfering RNAs to treat renal and hepatic disorders, and aptamers to combat ocular and cardiovascular disease. Results from these studies are generating considerable interest among the biomedical community and the public and will be important for the future development of this emerging class of therapeutic agents.
登录
查看更多内容
影响因子:
64.5
作者:
Niu, Yuyu;Shen, Bin;Sha, Jiahao
通讯作者:
Sha, Jiahao
影响因子:
168.9
作者:
Lincoff, A. Michael;Mehran, Roxana;Alexander, John H.
通讯作者:
Alexander, John H.
影响因子:
64.8
作者:
Mitchell DA;Batich KA;Gunn MD;Huang MN;Sanchez-Perez L;Nair SK;Congdon KL;Reap EA;Archer GE;Desjardins A;Friedman AH;Friedman HS;Herndon JE 2nd;Coan A;McLendon RE;Reardon DA;Vredenburgh JJ;Bigner DD;Sampson JH
通讯作者:
Sampson JH
影响因子:
56.9
作者:
Lan, N;Howrey, RP;Sullenger, BA
通讯作者:
Sullenger, BA
影响因子:
64.8
作者:
Rusconi, CP;Scardino, E;Sullenger, BA
通讯作者:
Sullenger, BA